We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
-4.27%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.5B
AUM Growth
-$123M
(-0.5%)
Cap. Flow
+$15.2B
Cap. Flow
% of AUM
62.04%
Top 10 Holdings %
Top 10 Hldgs %
35.31%
Holding
1,687
New
95
Increased
1,038
Reduced
411
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.51B |
| 2 |
MakeMyTrip
MMYT
|
+$2.46B |
| 3 |
Trip.com Group
TCOM
|
+$797M |
| 4 |
Yum China
YUMC
|
+$544M |
| 5 |
Alibaba
BABA
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.7M |
| 2 |
Pfizer
PFE
|
+$81.1M |
| 3 |
Blackrock
BLK
|
+$71.8M |
| 4 |
US Bancorp
USB
|
+$51.4M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.26% |
| 2 | Consumer Discretionary | 9.29% |
| 3 | Communication Services | 9.15% |
| 4 | Healthcare | 7.13% |
| 5 | Financials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Fate Therapeutics
FATE
$317M
| $3.35K | ﹤0.01% |
3,942
+147
| +4% | +$180 |
|
1527
Denison Mines
DNN
$2.98B
| $3.32K | ﹤0.01% |
+4,313
| New | +$7.2K |
|
1528
Pliant Therapeutics
PLRX
$66.3M
| $2.99K | ﹤0.01% |
2,036
+8
| +0.4% | +$49 |
|
1529
Kyverna Therapeutics
KYTX
$489M
| $2.89K | ﹤0.01% |
1,445
+6
| +0.4% | +$18 |
|
|
CLYM
1530
Climb Bio
CLYM
$827M
| $2.88K | ﹤0.01% |
2,249
+9
| +0.4% | +$15 |
|
1531
Biomea Fusion
BMEA
$92.8M
| $2.83K | ﹤0.01% |
1,230
+22
| +2% | +$75 |
|
1532
United States Natural Gas Fund
UNG
$500M
| $2.67K | ﹤0.01% |
125
-5
| -4% | -$99 |
|
1533
MacroGenics
MGNX
$256M
| $2.65K | ﹤0.01% |
2,100
+9
| +0.4% | +$24 |
|
|
ARTV
1534
Artiva Biotherapeutics
ARTV
$564M
| $2.57K | ﹤0.01% |
813
+4
| +0.5% | +$22 |
|
1535
Acrivon Therapeutics
ACRV
$73.6M
| $2.33K | ﹤0.01% |
1,042
+4
| +0.4% | +$22 |
|
1536
Pyxis Oncology
PYXS
$201M
| $2.11K | ﹤0.01% |
1,990
+8
| +0.4% | +$11 |
|
1537
TScan Therapeutics
TCRX
$50.5M
| $2.1K | ﹤0.01% |
1,556
-80
| -5% | -$173 |
|
|
APLT
1538
DELISTED
Applied Therapeutics
APLT
| $1.97K | ﹤0.01% |
3,819
-58
| -1% | -$34 |
|
1539
Sutro Biopharma
STRO
$353M
| $1.97K | ﹤0.01% |
268
-7
| -3% | -$110 |
|
|
INZY
1540
DELISTED
Inozyme Pharma
INZY
| $1.89K | ﹤0.01% |
2,054
-87
| -4% | -$121 |
|
|
OKUR
1541
OnKure Therapeutics
OKUR
$159M
| $1.89K | ﹤0.01% |
423
+1
| +0.2% | +$6 |
|
1542
Toast
TOST
$19.7B
| $1.59K | ﹤0.01% |
52,840
+49,703
| +1,584% | +$1.86M |
|
|
MRSN
1543
DELISTED
Mersana Therapeutics
MRSN
| $1.57K | ﹤0.01% |
165
| – | – |
|
1544
Uranium Energy
UEC
$5.62B
| $1.56K | ﹤0.01% |
+7,476
| New | +$46.9K |
|
1545
iShares Global Infrastructure ETF
IGF
$10.7B
| $1.53K | ﹤0.01% |
41,503
-370
| -0.9% | -$19.8K |
|
1546
PepGen
PEPG
$201M
| $1.51K | ﹤0.01% |
1,021
-65
| -6% | -$134 |
|
|
KEEL
1547
Keel Infrastructure Corp
KEEL
$2.19B
| $1.44K | ﹤0.01% |
1,137
+88
| +8% | +$117 |
|
1548
Glaukos
GKOS
$11B
| $1.43K | ﹤0.01% |
+14
| New | +$1.87K |
|
|
IGMS
1549
DELISTED
IGM Biosciences
IGMS
| $1.33K | ﹤0.01% |
1,077
-59
| -5% | -$110 |
|
1550
Cipher Digital
CIFR
$7.42B
| $1.17K | ﹤0.01% |
2,682
+1,797
| +203% | +$8.18K |
|
Similar funds
Mirae Asset Global Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Mirae Asset Global Investments held 1,687 positions worth $24.5B, down 0.5% from $24.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mirae Asset Global Investments deployed $15.2B of net new capital in Q1 2025, opening 95 new positions and adding to 1,038 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.7M trimmed.
- Mirae Asset Global Investments's largest Q1 2025 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
- Mirae Asset Global Investments added most to Pinduoduo in Q1 2025, an estimated $4.51B increase.
- Mirae Asset Global Investments's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.7M.
- Mirae Asset Global Investments fully exited State Street Utilities Select Sector SPDR ETF in Q1 2025, selling an estimated $8.71M.
- Mirae Asset Global Investments's ten largest holdings make up 35% of its $24.5B portfolio in Q1 2025.
- Mirae Asset Global Investments opened 95 new positions and closed 99 in Q1 2025.
- Mirae Asset Global Investments's portfolio value fell 0.5% quarter-over-quarter to $24.5B.
Based on Mirae Asset Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.